128 related articles for article (PubMed ID: 11843915)
1. In vitro susceptibility of Mycobacterium tuberculosis to fusidic acid.
Cicek-Saydam C; Cavusoglu C; Burhanoglu D; Hilmioglu S; Ozkalay N; Bilgic A
Clin Microbiol Infect; 2001 Dec; 7(12):700-2. PubMed ID: 11843915
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of mycobacteria to fusidic acid.
Hoffner SE; Olsson-Liljequist B; Rydgård KJ; Svenson SB; Källenius G
Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):294-7. PubMed ID: 2112466
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
Fabry W; Schmid EN; Ansorg R
Zentralbl Bakteriol; 1995 Oct; 282(4):394-401. PubMed ID: 9810662
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of strains of the Mycobacterium tuberculosis complex to fusidic acid.
Fuursted K; Askgaard D; Faber V
APMIS; 1992 Jul; 100(7):663-7. PubMed ID: 1642855
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologically active metabolites, combination screening and target identification-driven drug repositioning in antituberculosis drug discovery.
Kigondu EM; Wasuna A; Warner DF; Chibale K
Bioorg Med Chem; 2014 Aug; 22(16):4453-61. PubMed ID: 24997576
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis.
Akcali S; Surucuoglu S; Cicek C; Ozbakkaloglu B
Ann Saudi Med; 2005; 25(5):409-12. PubMed ID: 16270765
[TBL] [Abstract][Full Text] [Related]
7. A high throughput methodology for susceptibility testing of Mycobacterium tuberculosis isolates.
Rampersad T; Makume M; Sobia P; Willem Sturm A
J Microbiol Methods; 2018 Mar; 146():64-67. PubMed ID: 29410256
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.
Vera-Cabrera L; Castro-Garza J; Rendon A; Ocampo-Candiani J; Welsh O; Choi SH; Blackwood K; Molina-Torres C
Antimicrob Agents Chemother; 2005 Oct; 49(10):4351-3. PubMed ID: 16189119
[TBL] [Abstract][Full Text] [Related]
9. Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.
Djemal SE; Camperio C; Armas F; Siala M; Smaoui S; Messadi-Akrout F; Gdoura R; Marianelli C
BMC Vet Res; 2018 Sep; 14(1):296. PubMed ID: 30268120
[TBL] [Abstract][Full Text] [Related]
10. Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children.
Schaaf HS; Victor TC; Engelke E; Brittle W; Marais BJ; Hesseling AC; van Helden PD; Donald PR
Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):203-5. PubMed ID: 17294161
[TBL] [Abstract][Full Text] [Related]
11. Characterization of phenotypic and genotypic drug resistance patterns of Mycobacterium tuberculosis isolates from a city in Mexico.
Flores-Treviño S; Morfín-Otero R; Rodríguez-Noriega E; González-Díaz E; Pérez-Gómez HR; Mendoza-Olazarán S; Balderas-Rentería I; González GM; Garza-González E
Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):181-5. PubMed ID: 24953252
[TBL] [Abstract][Full Text] [Related]
12. [Surveillance of antituberculosis-drug resistance in Cuba, 2010-2011].
Lemus D; Echemendía M; Díaz R; Llop A; Llanes MJ
Biomedica; 2014 Apr; 34 Suppl 1():108-13. PubMed ID: 24968042
[TBL] [Abstract][Full Text] [Related]
13. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis.
Verma JS; Nair D; Rawat D; Manzoor N
Indian J Med Microbiol; 2011; 29(3):280-2. PubMed ID: 21860110
[TBL] [Abstract][Full Text] [Related]
14. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
[TBL] [Abstract][Full Text] [Related]
16. Rv0684/
Singh V; Dziwornu GA; Mabhula A; Chibale K
ACS Infect Dis; 2021 Aug; 7(8):2437-2444. PubMed ID: 34196521
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to fusidic acid among Danish Staphylococcus aureus strains and fusidic acid consumption.
Faber M; Rosdahl VT
J Antimicrob Chemother; 1990 Feb; 25 Suppl B():7-14. PubMed ID: 2312446
[TBL] [Abstract][Full Text] [Related]
19. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
[TBL] [Abstract][Full Text] [Related]
20. Increasing resistance to fusidic acid among clinical isolates of MRSA.
Wang JT; Huang IW; Chang SC; Tan MC; Lai JF; Chen PY; Lauderdale TL
J Antimicrob Chemother; 2017 Feb; 72(2):616-618. PubMed ID: 27733516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
